“HIV patients in Thai National Treatment program switching to second-line antiretroviral therapy have 9.8% cumulative virological failure rate at 6 years, with women and those with lower CD4 counts at switch at higher risk”

https://pubmed.ncbi.nlm.nih.gov/38115729

The study found that people living with HIV who switched to second-line antiretroviral therapy in the Thai National Treatment program had a cumulative virological failure rate of 9.8% at 6 years, with women and those with lower CD4 counts at switch having the highest risk.